PharmAust has released a comprehensive update on its clinical trial evaluating the anti- cancer benefit of MPL in dogs newly diagnosed with B-cell lymphoma cdn-api.markitdigital.com/apiman-gateway…

$19 per month for Twitter subscription!

Elsie Cox: Baby survives being born with external organs news.com.au/lifestyle/heal… via news.com.au WesElyMD @KristinCollie20 Milad Sharifpour, MD A beautiful reminder of how wonderful medical professionals are the world over: wisdom, teamwork & love for helping others. Thank you all💙

Great news @PharmAust ! 💙

All hospitals should have dogs visits 😍😍

Mesoblast News Wow! Survive & thrive! Well done Team Mesoblast 💙

Fantastic work Team Mesoblast News!

Exciting news! 💙

Fantastic news @PharmAust! Exciting & hope-filled times ahead! 💙

Great to see the word spreading The Texas Heart Institute & Mesoblast News ! “The data revealed that the treatment gave patients a “58 percent reduced risk of heart attack or stroke, and the benefits rose to 75 percent in patients with high inflammation,” Dr Perin noted. europeanpharmaceuticalreview.com/article/182527…

Fantastic news! 💙

Great news! 💙

Great work @PharmAust. Changing lives for the better & giving hope to those with MND & their families! 💙

Fantastic results @PharmAust. Increasing life-expectancy for those suffering from terrible MND. Incredible & life-giving! Well done PAA & thank you to the trial participants & FightMND. May Monepantel continue to do its work! 💙

💙

Great presentation Roger Blumenthal Insightful & thought provoking. For the non-medical person, it gives clear steps of how we should be living in partnership with healthcare providers. So much we can do to help ourselves. 💙 Kept it real too with the sport! youtu.be/5fwEyqT8P9o?si…

Today’s good news story! 💙

$BOT is very pleased to announce the US FDA approval of Sofdra™ (sofpironium) topical gel, 12.45%. Sofdra is a prescription medicine used to treat primary axillary hyperhidrosis (excessive underarm sweating) in adults and children 9 years and older. bit.ly/BOT-Sofdra-App…

Mesoblast News Survive & thrive! 💙

Congratulations to Dr Silviu Itescu & Mesoblast News Team for your persistence. You work hard & you get there in the end. First!!! Sick & dying children will survive & thrive due to your innovation & dedication! 💙